4.5 Article

The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping

期刊

EUROPEAN JOURNAL OF NEUROSCIENCE
卷 40, 期 7, 页码 3055-3066

出版社

WILEY
DOI: 10.1111/ejn.12672

关键词

AP lesion; meal pattern analysis; noradrenaline; rat; VGLUT2

资金

  1. Novo Nordisk
  2. Swiss National Science Foundation
  3. NIH [DK 092608]

向作者/读者索取更多资源

Amylin reduces meal size by activating noradrenergic neurons in the area postrema (AP). Neurons in the AP also mediate the eating-inhibitory effects of salmon calcitonin (sCT), a potent amylin agonist, but the phenotypes of the neurons mediating its effect are unknown. Here we investigated whether sCT activates similar neuronal populations to amylin, and if its anorectic properties also depend on AP function. Male rats underwent AP lesion (APX) or sham surgery. Meal patterns were analysed under ad libitum and post-deprivation conditions. The importance of the AP in mediating the anorectic action of sCT was examined in feeding experiments of dose-response effects of sCT in APX vs. sham rats. The effect of sCT to induce Fos expression was compared between surgery groups, and relative to amylin. The phenotype of Fos-expressing neurons in the brainstem was examined by testing for the co-expression of dopamine beta hydroxylase (DBH) or tryptophan hydroxylase (TPH). By measuring the apposition of vesicular glutamate transporter-2 (VGLUT2)-positive boutons, potential glutamatergic input to amylin- and sCT-activated AP neurons was compared. Similar to amylin, an intact AP was necessary for sCT to reduce eating. Further, co-expression between Fos activation and DBH after amylin or sCT did not differ markedly, while co-localization of Fos and TPH was minor. Approximately 95% of neurons expressing Fos and DBH after amylin or sCT treatment were closely apposed to VGLUT2-positive boutons. Our study suggests that the hindbrain pathways engaged by amylin and sCT share many similarities, including the mediation by AP neurons.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus

Elisa S. Roesti, Christina N. Boyle, Daniel T. Zeman, Marcos Sande-Melon, Federico Storni, Gustavo Cabral-Miranda, Alexander Knuth, Thomas A. Lutz, Monique Vogel, Martin F. Bachmann

VACCINES (2020)

Article Endocrinology & Metabolism

Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes

Catherine Gibbons, John Blundell, Soren Tetens Hoff, Kirsten Dahl, Robert Bauer, Tine Baekdal

Summary: Oral semaglutide can reduce energy intake in patients with type 2 diabetes, leading to decreased body fat mass, increased satiety and hunger, and improved eating control.

DIABETES OBESITY & METABOLISM (2021)

Article Biochemistry & Molecular Biology

Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity

Dominik Pretz, Christelle Le Foll, Mohammed Z. Rizwan, Thomas A. Lutz, Alexander Tups

Summary: High levels of leptin may exacerbate weight gain and gliosis in the hypothalamus of obese mice on a high-fat diet, while a long-acting leptin antagonist could improve glucose tolerance and reduce the number of glial cells in the hypothalamus of diet-induced obese mice.

FASEB JOURNAL (2021)

Article Chemistry, Medicinal

Development of Cagrilintide, a Long-Acting Amylin Analogue

Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl, Lauge Schaffer, Ulrich Sensfuss, Christian Poulsen, Morten Schlein, Ann Maria Kruse Hansen, Claus Bekker Jeppesen, Charlotta Dornonville de la Cour, Trine Ryberg Clausen, Eva Johansson, Simone Fulle, Rikke Bjerring Skyggebjerg, Kirsten Raun

Summary: This article presents the development of a stable, lipidated long-acting amylin analogue called cagrilintide, which has shown significant weight loss effects in clinical trials, either alone or in combination with the GLP-1 analogue semaglutide. Adjustment of structure-activity relationships led to the selection of cagrilintide for clinical development as a treatment for obesity.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Psychology, Biological

Hypoglycemia attenuates acute amylin-induced reduction of food intake in male rats

Miriam Honegger, Thomas A. Lutz, Christina N. Boyle

Summary: The ability of amylin to inhibit food intake is reduced under hypoglycemic conditions, possibly due to the co-sensitivity of AP neurons to amylin and glucose. Amylin can also buffer meal-induced glucose appearance at EU and HYPO levels.

PHYSIOLOGY & BEHAVIOR (2021)

Article Agriculture, Dairy & Animal Science

Effect of tetra-hydroxylated bile acid on size and insulin sensitivity of subcutaneous adipocytes in healthy lean cats

I. T. Rast, E. Zini, C. Wolfrum, T. A. Lutz, C. E. Reusch, E. Salesov

Summary: Obesity leads to insulin resistance and is a major risk factor for the development of diabetes mellitus in cats. ROR gamma and its target gene MMP3 play a key role in the development of large insulin-resistant adipocytes. THBA inhibits ROR gamma, reduces adipocyte size, and improves insulin sensitivity.

DOMESTIC ANIMAL ENDOCRINOLOGY (2022)

Article Biochemistry & Molecular Biology

The Deubiquitinase OTUB1 Is a Key Regulator of Energy Metabolism

Amalia Ruiz-Serrano, Christina N. Boyle, Josep M. Monne Rodriguez, Julia Guenter, Agnieszka E. Jucht, Svende Pfundstein, Andreas M. Bapst, Thomas A. Lutz, Roland H. Wenger, Carsten C. Scholz

Summary: Dysregulated energy metabolism is a major cause of various diseases. OTUB1 plays an important regulatory role in energy metabolism. Deletion of OTUB1 in mice leads to increased energy expenditure and improved glucose metabolism.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Mouse Microglial Calcitonin Receptor Knockout Impairs Hypothalamic Amylin Neuronal pSTAT3 Signaling but Lacks Major Metabolic Consequences

Bernd Coester, Thomas A. Lutz, Christelle Le Foll

Summary: This study suggests that microglial amylin signaling is not a major player in the control of energy homeostasis in mice, as male mice with depleted CTR in microglia did not show significant differences in weight and metabolism compared to mice without depletion.

METABOLITES (2022)

Article Behavioral Sciences

Creating the amylin story

Thomas A. Lutz

Summary: This paper is a personal view on the milestones in the discovery of amylin and its roles in physiology and pathophysiology. Amylin, found in islet amyloid deposits in type 2 diabetics, contributes to beta-cell damage and has diverse metabolic functions, including inhibition of eating and pancreatic glucagon secretion. The knowledge of these functions has led to the development of amylin analogues as promising anti-obesity targets.

APPETITE (2022)

Article Multidisciplinary Sciences

Effects of acute administration of trimethylamine N-oxide on endothelial function: a translational study

Anne Jomard, Luca Liberale, Petia Doytcheva, Martin F. Reiner, Daniel Muller, Michele Visentin, Marco Bueter, Thomas F. Luscher, Roberto Vettor, Thomas A. Lutz, Giovanni G. Camici, Elena Osto

Summary: The study found that elevated levels of plasmatic TMAO within the near-physiological range appear to be neutral bystanders to vascular function, as observed in patients after bariatric surgery, healthy lean rodent models, and endothelial cells acutely exposed to TMAO.

SCIENTIFIC REPORTS (2022)

Review Medicine, General & Internal

Mediators of Amylin Action in Metabolic Control

Christina N. Boyle, Yi Zheng, Thomas A. Lutz

Summary: Amylin, a pancreatic beta-cell hormone, plays important physiological roles in metabolic control, such as regulating satiation, gastric emptying, and glucagon secretion. Amylin analogs have emerged as promising approaches for obesity and diabetes treatment.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale

Erica R. R. Hendrikse, Tayla A. A. Rees, Zoe Tasma, Michael L. L. Garelja, Andrew Siow, Paul W. R. Harris, John B. B. Pawlak, Kathleen M. M. Caron, Elizabeth S. S. Blakeney, Andrew F. F. Russo, Levi P. P. Sowers, Thomas A. A. Lutz, Christelle Le Foll, Christopher S. S. Walker, Debbie L. L. Hay

Summary: This study evaluated antibodies for the detection of RAMP1 protein and found that two antibodies could detect a RAMP1-like band in rodent brain tissue, but with cross-reactivity to other proteins. The anatomical localization of RAMP1 in the brain could not be determined, highlighting the need for comprehensive validation of RAMP1 antibodies. This research has broader implications for GPCR/ligand pairings beyond the field of CGRP.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Endocrinology & Metabolism

Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus

Thomas A. A. Lutz

Summary: Although small rodents are the most widely used animal models to study diabetes mellitus, non-rodent species like pigs, cats, and dogs also provide valuable insights. Animal models, including both rodents and non-rodent species, are essential for studying energy balance, metabolism control, and the development of metabolic diseases like type 2 diabetes mellitus. This Review outlines the advantages and disadvantages of selected animal models and aims to establish a basis for their appropriate use in biomedical research.

NATURE REVIEWS ENDOCRINOLOGY (2023)

暂无数据